Walled Lake Planning & Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Walled Lake Planning & Wealth Management's PFE Position: Q2 2026 in Review
Walled Lake Planning & Wealth Management reduced its Pfizer (PFE) stake by 0.86% in Q2 2026, selling an estimated $27.2K and leaving 119,517 shares worth $2.88M. The position accounts for 0.73% of the portfolio, ranked #31.
Walled Lake Planning & Wealth Management first reported a position in PFE in Q4 2019 and has held it in 24 quarters since. The position peaked at $5.61M in Q4 2021. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Walled Lake Planning & Wealth Management held 119,517 shares of Pfizer worth $2.88M as of Q2 2026.
- Walled Lake Planning & Wealth Management sold 1,038 Pfizer shares in Q2 2026, an estimated $27.2K.
- Pfizer made up 0.73% of Walled Lake Planning & Wealth Management's portfolio in Q2 2026, its #31 holding.
- Walled Lake Planning & Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 24 quarters since.
- Walled Lake Planning & Wealth Management's Pfizer position peaked at $5.61M in Q4 2021.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Walled Lake Planning & Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.